Zhejiang Medicine Co., Ltd. (600216) - Financial and Strategic SWOT
Analysis Review
Reference Code: GDPH81640FSA Publication Date: SEP 2012
No.268 Dengyun Road, Gongshu
Phone +86 571 87220660 Revenue 4,826 (million CNY)
District
Hangzhou, ZHJ Fax +86 571 87213793 Net Profit 1,012.48 (million CNY)
310011 Website www.china-zmc.com Employees 4,666 (Estimated)
600216 [Shanghai Pharmaceuticals &
China Exchange Industry
Stock Exchange] Healthcare
Company Overview
Zhejiang Medicine Co., Ltd. (Zhejiang Medicine) is a biopharmaceutical company specializing in production of high-quality
biological drugs, pharmaceutical intermediates and bio-pesticides. It undertakes development, marketing and maufacture of drug
substances, finished formulatins and food. The company's product portfolio consists of health creation natural vitamin E soft
capsule, vancomycin hydrochloride for injection, levofloxacin lactate tablets, progesterone soft capsules and teicoplanin for
injection. The company sells its products under brand names of Levofloxacin Lactate, Nature Vitamin E SOFT CAPSULE and
synthesized Synthetic Vitamin E, Rifampicin, VH (D-Biotin), and Kitasamycin.
Key Executives SWOT Analysis
Name Title Zhejiang Medicine Co., Ltd., SWOT Analysis
Chunfeng Li Chief Financial Officer Strengths Weaknesses
Xiaoyue Jiang Director
Improved Liquidity Position Operating Inefficiency
Chunlei Lu Director
Broad Product Portfolio Litigations
Chunbo Li Chairman
Guojun Zhang Vice Chairman
Source: Annual Report, Company Website, Primary and Secondary
Opportunities Threats
Research, GlobalData
Rapid Growth in China’s Competitive Pressures
Share Data Pharmaceutical Market
Government Regulations
Zhejiang Medicine Co., Ltd.
Changing Demographics
Share Price (CNY) as on 17-Sep- 21.64
2012
Source: Annual Report, Company Website, Primary and Secondary Research,
EPS (CNY) 2.25 GlobalData
Market Cap (million CNY) 10,036
Enterprise Value (million CNY) 8,382
Shares Outstanding (million) 450
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData
Financial Performance Recent Developments
Jun 20, 2012 Zhejiang Medicine To Invest RMB158m In
New Subsidiary
Source: Annual Report, Company Website, Primary and Secondary Research,
GlobalData
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData
Zhejiang Medicine Co., Ltd. (600216) - Financial and Strategic Reference Code: GDPH81640FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Table of Contents
Table of Contents ............................................................................................................................................................................... 2
List of Tables .................................................................................................................................................................................. 3
List of Figures ................................................................................................................................................................................. 3
Section 1 - About the Company.......................................................................................................................................................... 4
Zhejiang Medicine Co., Ltd. - Key Facts ............................................................................................................................................. 4
Zhejiang Medicine Co., Ltd. - Key Employees .................................................................................................................................... 5
Zhejiang Medicine Co., Ltd. - Key Employee Biographies .................................................................................................................. 6
Zhejiang Medicine Co., Ltd. - Major Products and Services ............................................................................................................... 7
Zhejiang Medicine Co., Ltd. - History ................................................................................................................................................. 8
Zhejiang Medicine Co., Ltd. - Locations And Subsidiaries.................................................................................................................. 9
Head Office ..................................................................................................................................................................................... 9
Other Locations & Subsidiaries ....................................................................................................................................................... 9
Section 2 – Company Analysis ......................................................................................................................................................... 10
Zhejiang Medicine Co., Ltd. - Business Description ......................................................................................................................... 10
Zhejiang Medicine Co., Ltd. - Corporate Strategy ............................................................................................................................ 12
Zhejiang Medicine Co., Ltd. - SWOT Analysis.................................................................................................................................. 13
SWOT Analysis - Overview........................................................................................................................................................... 13
Zhejiang Medicine Co., Ltd. - Strengths ........................................................................................................................................ 13
Strength - Improved Liquidity Position ....................................................................................................................................... 13
Strength - Broad Product Portfolio ............................................................................................................................................ 13
Strength - Consistent Increase in Revenue ............................................................................................................................... 13
Zhejiang Medicine Co., Ltd. - Weaknesses................................................................................................................................... 13
Weakness - Operating Inefficiency ............................................................................................................................................ 13
Weakness - Litigations .............................................................................................................................................................. 14
Zhejiang Medicine Co., Ltd. - Opportunities .................................................................................................................................. 14
Opportunity - Rapid Growth in China’s Pharmaceutical Market ................................................................................................ 14
Opportunity - Changing Demographics ..................................................................................................................................... 14
Opportunity - Inorganic Growth Strategies ................................................................................................................................ 14
Zhejiang Medicine Co., Ltd. - Threats ........................................................................................................................................... 15
Threat - Competitive